Im not recommending this approach
The backbone is primarily built on a GIP receptor agonist scaffold, which was then systematically modified to introduce cross-reactivity at the GLP-1 and glucagon receptors
Ochratoxin and trichothecenes, on the other hand, can have implications for kidney health and compromise the immune system
Recent studies have demonstrated differential expression patterns of Fetuin-A in neurological disorders such as PD, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS) [129,130,131]
Gastroenterology 156 , 10271040.e1023 (2019)
The appetite-suppressing effects wear off within a few weeks of your last dose